Her2-positive early breast cancer Clinical Trials

Delta Trials records 8 clinical trials for Her2-positive early breast cancer in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 3 trials have reached completion. This research is conducted across 188 study locations around the world. An additional 2 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.